Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Consolidated Results for the First Three Months of the Fiscal Year Ending September 30, 2026 (based on Japan GAAP)
Noevir, Oct-Dec (1Q) Ordinary Profit Decreases by 26%
Matters Concerning Controlling Shareholder, Etc.
Changes among Representative Director, Directors, Audit & Supervisory Board Members, and Executive Officers
Corporate Governance Report
Dividend Distribution from Retained Earnings
Noevir, 0.2% Increase in Ordinary Profit for The Current Fiscal Year, Increased Previous Year's Dividend by 5 Yen, Plan to Continue the 230 Yen Policy This Fiscal Year as Well
Notice Concerning Partial Amendment to the Articles of Incorporation
Changes among Representative Directors and Directors of Subsidiary Companies
Noevir Holdings Announces 2025 Consolidated Results (based on Japan GAAP)
Consolidated Results for the First Nine Months of the Fiscal Year Ending September 30, 2025
Noevir, Oct-Jun (Cumulative 3Q) Ordinary Profit Decreases by 8%, Apr-Jun Ordinary Profit Decreases by 18%
Consolidated Results for the First Six Months of the Fiscal Year Ending September 30, 2025
Noevir, First Half Ordinary Profit Decreases by 4%
Summary of Financial Results for the first quarter 2025
Noevir, Oct-Dec (1Q) Ordinary Profit Decreases by 8%
Noevir Holdings Co.,Ltd., 1% Increase in Ordinary Profit for The Current Fiscal Year, Increased Previous Year's Dividend by 5 yen, Plan to continue the 225 yen policy this fiscal year as well
Summary of Financial Results 2024